Transcripts Cytosorbents Corporation

Equities

CTSO

US23283X2062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
0.9001 ^USD	+2.28%		+0.01%	-18.91%

May. 09	Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M	MT
May. 09	Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024

Transcripts

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024	May. 09
Transcript : Cytosorbents Corporation - Analyst/Investor Day	May. 06
Transcript : Cytosorbents Corporation, Q4 2023 Earnings Call, Mar 14, 2024	Mar. 14
Transcript : Cytosorbents Corporation, Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Transcript : Cytosorbents Corporation, Q2 2023 Earnings Call, Aug 01, 2023	23-08-01
Transcript : Cytosorbents Corporation, Q1 2023 Earnings Call, May 02, 2023	23-05-02
Transcript : Cytosorbents Corporation, Q4 2022 Earnings Call, Mar 09, 2023	23-03-09
Transcript : Cytosorbents Corporation, Q3 2022 Earnings Call, Nov 03, 2022	22-11-03
Transcript : Cytosorbents Corporation, Q2 2022 Earnings Call, Aug 02, 2022	22-08-02
Transcript : Cytosorbents Corporation Presents at UBS Global Healthcare Conference, May-23-2022 09:15 AM	22-05-23
Transcript : Cytosorbents Corporation, Q1 2022 Earnings Call, May 03, 2022	22-05-03
Transcript : Cytosorbents Corporation, Q4 2021 Earnings Call, Mar 08, 2022	22-03-08
Cytosorbents Corporation Provides Revenue Guidance for the Full Year 2022	22-03-08	CI
Transcript : Cytosorbents Corporation, Q3 2021 Earnings Call, Nov 04, 2021	21-11-04
Cytosorbents Corporation Reaffirms Revenue Guidance for the Fourth Quarter and Full Year of 2021	21-11-04	CI
Cytosorbents Corporation Revises Revenue Guidance for the Fourth Quarter and Full Year of 2021	21-10-12	CI
Transcript : Cytosorbents Corporation - Special Call	21-09-16
Transcript : Cytosorbents Corporation, Q2 2021 Earnings Call, Aug 03, 2021	21-08-03
Cytosorbents Corporation Provides Sales Guidance for the Second Half and Full Year 2021	21-08-03	CI
Transcript : Cytosorbents Corporation - Shareholder/Analyst Call	21-06-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Cytosorbents Corporation

Equities

CTSO

US23283X2062

Transcripts

Filters